Merck Escapes Some Injury Claims In Fosamax MDL

Law360, Los Angeles (March 26, 2014, 7:06 PM EDT) -- A New Jersey federal judge on Wednesday tossed some claims brought against Merck & Co. Inc. in multidistrict litigation accusing the company of negligence over femur fractures and similar injuries allegedly caused by its osteoporosis drug Fosamax, saying those claims are preempted.

Last June, in a related case known as Glynn v. Merck, U.S. District Judge Joel A. Pisano said that claims that Merck had failed to warn a consumer of the possible risk of femur fractures from the use Fosamax were preempted under federal law...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

MOLNAR et al v. MERCK & CO., INC.


Case Number

3:08-cv-00008

Court

New Jersey

Nature of Suit

Personal Inj. Prod. Liability

Judge

Freda L. Wolfson

Date Filed

January 2, 2008

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.